Clinical Proteomics

Papers
(The TQCC of Clinical Proteomics is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-01-01 to 2025-01-01.)
ArticleCitations
Quantitative proteomics analysis in small cell carcinoma of cervix reveals novel therapeutic targets40
Proteome analysis of CD5-positive diffuse large B cell lymphoma FFPE tissue reveals downregulation of DDX3X, DNAJB1, and B cell receptor signaling pathway proteins including BTK and Immunoglobulins33
Proteome profiling of human placenta reveals developmental stage-dependent alterations in protein signature25
Functional and quantitative evaluation of the 20S proteasome in serum and intracellular in145 moroccan patients with hematologic malignancies24
Glycoproteomics revealed novel N-glycosylation biomarkers for early diagnosis of lung adenocarcinoma cancers19
Many kinds of oxidized proteins are present more in the urine of the elderly19
13C15N: glucagon-based novel isotope dilution mass spectrometry method for measurement of glucagon metabolism in humans18
Redefining serological diagnostics with immunoaffinity proteomics17
The use of proteomics for blood biomarker research in premature infants: a scoping review17
Development of an ID-LC–MS/MS method using targeted proteomics for quantifying cardiac troponin I in human serum16
Comparative proteomic analysis of glomerular proteins in primary and bucillamine-induced membranous nephropathy16
Label-free LC–MS/MS proteomics analyses reveal proteomic changes in oxidative stress and the SOD antioxidant strategy in TM cells16
Multiplex proteomics identifies inflammation-related plasma biomarkers for aging and cardio-metabolic disorders15
Rational selection of a biomarker panel targeting unmet clinical needs in kidney injury15
Changes of serum IgG glycosylation patterns in rheumatoid arthritis14
Kinase inhibitor pulldown assay (KiP) for clinical proteomics13
Glial fibrillary acidic protein, neurofilament light, matrix metalloprotease 3 and fatty acid binding protein 4 as non-invasive brain tumor biomarkers13
Serum proteomics of severe fever with thrombocytopenia syndrome patients12
sBioSITe enables sensitive identification of the cell surface proteome through direct enrichment of biotinylated peptides12
Validation and update of a multivariable prediction model for the identification and management of patients at risk for hepatocellular carcinoma12
Systematic evaluation and optimization of protein extraction parameters in diagnostic FFPE specimens12
Transcriptome profiling and proteomic validation reveals targets of the androgen receptor signaling in the BT-474 breast cancer cell line12
Quantitative proteomics-based analyses performed on pre-eclampsia samples in the 2004–2020 period: a systematic review11
Change of histone H3 lysine 14 acetylation stoichiometry in human monocyte derived macrophages as determined by MS-based absolute targeted quantitative proteomic approach: HIV infection and methamphet11
Orthogonal proteomics methods warrant the development of Duchenne muscular dystrophy biomarkers11
Recent developments in mass-spectrometry-based targeted proteomics of clinical cancer biomarkers11
Characterizing age-related changes in intact mitochondrial proteoforms in murine hearts using quantitative top-down proteomics10
The novel biomarkers for assessing clinical benefits of continuous renal replacement therapy in pediatric sepsis: a pilot study10
Systematic review of type 1 diabetes biomarkers reveals regulation in circulating proteins related to complement, lipid metabolism, and immune response10
Circulating microvesicles and exosomes in small cell lung cancer by quantitative proteomics10
The dynamic changes and sex differences of 147 immune-related proteins during acute COVID-19 in 580 individuals10
Proteomic signature associated with chronic kidney disease (CKD) progression identified by data-independent acquisition mass spectrometry9
Changes in amino acid concentrations and the gut microbiota composition are implicated in the mucosal healing of ulcerative colitis and can be used as noninvasive diagnostic biomarkers9
Kinome and phosphoproteome reprogramming underlies the aberrant immune responses in critically ill COVID-19 patients8
Phospho-heavy-labeled-spiketide FAIMS stepped-CV DDA (pHASED) provides real-time phosphoproteomics data to aid in cancer drug selection8
Application of urine proteomics in the diagnosis and treatment effectiveness monitoring of early-stage Mycosis Fungoides7
Development of a predictive model to distinguish prostate cancer from benign prostatic hyperplasia by integrating serum glycoproteomics and clinical variables7
Decreased histidine-rich glycoprotein and increased complement C4-B protein levels in follicular fluid predict the IVF outcomes of recurrent spontaneous abortion7
Recent progress in mass spectrometry-based urinary proteomics7
Label-free quantitative proteomic analysis of serum exosomes from patients of renal anemia: The Good and the Bad of Roxadustat7
Identification of brain-enriched proteins in CSF as biomarkers of relapsing remitting multiple sclerosis6
Optimized data-independent acquisition approach for proteomic analysis at single-cell level6
Quantitative proteomic analysis of HER2 protein expression in PDAC tumors6
Maternal serum CFHR4 protein as a potential non-invasive marker of ventricular septal defects in offspring: evidence from a comparative proteomics study6
Comment on “Cerebrospinal fluid camk2a levels at baseline predict long-term progression in multiple sclerosis. Clinical Proteomics”6
Correlation between small-cell lung cancer serum protein/peptides determined by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and chemotherapy efficacy6
Proteomic analysis of 92 circulating proteins and their effects in cardiometabolic diseases6
Combination of automated sample preparation and micro-flow LC–MS for high-throughput plasma proteomics6
Are the results from a multiplex proteomic assay and a conventional immunoassay for NT-proBNP and GDF-15 comparable?6
Validation of ANG-1 and P-SEL as biomarkers of post-COVID-19 conditions using data from the Biobanque québécoise de la COVID-19 (BQC-19)5
Mapping dynamic molecular changes in hippocampal subregions after traumatic brain injury through spatial proteomics5
Quantification of putative ovarian cancer serum protein biomarkers using a multiplexed targeted mass spectrometry assay5
Quantitative proteomics analysis based on data-independent acquisition reveals the effect of Shenling Baizhu powder (SLP) on protein expression in MAFLD rat liver tissue5
Using established biorepositories for emerging research questions: a feasibility study5
Resistin as a potential diagnostic biomarker for sepsis: insights from DIA and ELISA analyses5
Associations of circulating proteins with lipoprotein profiles: proteomic analyses from the OmniHeart randomized trial and the Atherosclerosis Risk in Communities (ARIC) Study5
The relationship between serum astroglial and neuronal markers and AQP4 and MOG autoantibodies5
Validation of the novel GLAS algorithm as an aid in the detection of liver fibrosis and cirrhosis based on GP73, LG2m, age, and sex5
Combined proteomic/transcriptomic signature of recurrence post-liver transplantation for hepatocellular carcinoma beyond Milan5
Integrative omics reveals subtle molecular perturbations following ischemic conditioning in a porcine kidney transplant model5
Frozen tissue coring and layered histological analysis improves cell type-specific proteogenomic characterization of pancreatic adenocarcinoma5
Proteome profiling of cutaneous leishmaniasis lesions due to dermotropic Leishmania donovani in Sri Lanka5
0.042036056518555